Table 4.
Aptamer-based nonodrug delivery systems on targeted therapy of cancer cells
| Aptamers | Nanomaterials | Target | Drugs | References |
|---|---|---|---|---|
| AS1411 | Carbon nanotubes | Nucleolin (gastric cancer) | DOX | 177 |
| AS1411 | PLGA NPs | Nucleolin (lung cancer) | Gemcitabine | 178 |
| EpCAM | Silica NPs | EpCAM (colon cancer) | DOX | 179 |
| A10-3-J1 | Super paramagnetic iron oxide NPs | PSMA (prostate cancer) | DOX | 180 |
| Sgc8c | Gold NPs | PTK7 (leukemia) | Daunorubicin | 181 |
| TSA14 | Liposome | TUBO breast cell line | DOX | 182 |
| 5TR1 | PLGA NPs | MUC1 (breast cancer) | Epirubicin | 183 |
| Endo28 | RNA NPs | Annexin A2 (ovarian cancer); EGFR (cervical cancer) | DOX | 184 |
| EGFR | Albumin NPs | PSMA (prostate cancer) | Cisplatin | 185 |
| A10 | PLGA NPs | TFO | 186 |